Search research articles
Contact Us
Filters
Showing results (11-20 of 136) with videos related to
Page
of 14
Sort By:
Psychopharmacology
|
September 28, 2004
A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features
Laura M Juliano, Roland R Griffiths
Drug and Alcohol Dependence
|
May 16, 2009
Principles of laboratory assessment of drug abuse liability and implications for clinical development
Lawrence P Carter, Roland R Griffiths
Psychopharmacology
|
March 8, 2007
A triazolam/amphetamine dose-effect interaction study: dissociation of effects on memory versus arousal
Miriam Z Mintzer, Roland R Griffiths
The Journal of Clinical Psychiatry
|
December 13, 2005
Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds
Roland R Griffiths, Matthew W Johnson
Experimental and Clinical Psychopharmacology
|
February 21, 2013
Comparative abuse liability of GHB and ethanol in humans
Matthew W Johnson, Roland R Griffiths
Human Psychopharmacology
|
January 26, 2017
The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Bouso et al., 2016
Frederick S Barrett, Roland R Griffiths
JAMA Psychiatry
|
February 10, 2021
Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder
Alan K Davis, Roland R Griffiths
Drug and Alcohol Dependence
|
May 22, 2003
Principles of drug abuse liability assessment in laboratory animals
Nancy A Ator, Roland R Griffiths
Psychopharmacology
|
September 29, 2004
Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure
Miriam Z Mintzer, Roland R Griffiths
Cognitive, Affective & Behavioral Neuroscience
|
August 4, 2007
Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes
Miriam Z Mintzer, Roland R Griffiths
Page
of 14
Search research articles
Search
Showing results (11-20 of 136) with videos related to
Sort By:
Page
of 14
Psychopharmacology
|
September 28, 2004
A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features
Laura M Juliano, Roland R Griffiths
Drug and Alcohol Dependence
|
May 16, 2009
Principles of laboratory assessment of drug abuse liability and implications for clinical development
Lawrence P Carter, Roland R Griffiths
Psychopharmacology
|
March 8, 2007
A triazolam/amphetamine dose-effect interaction study: dissociation of effects on memory versus arousal
Miriam Z Mintzer, Roland R Griffiths
The Journal of Clinical Psychiatry
|
December 13, 2005
Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds
Roland R Griffiths, Matthew W Johnson
Experimental and Clinical Psychopharmacology
|
February 21, 2013
Comparative abuse liability of GHB and ethanol in humans
Matthew W Johnson, Roland R Griffiths
Human Psychopharmacology
|
January 26, 2017
The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Bouso et al., 2016
Frederick S Barrett, Roland R Griffiths
JAMA Psychiatry
|
February 10, 2021
Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder
Alan K Davis, Roland R Griffiths
Drug and Alcohol Dependence
|
May 22, 2003
Principles of drug abuse liability assessment in laboratory animals
Nancy A Ator, Roland R Griffiths
Psychopharmacology
|
September 29, 2004
Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure
Miriam Z Mintzer, Roland R Griffiths
Cognitive, Affective & Behavioral Neuroscience
|
August 4, 2007
Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes
Miriam Z Mintzer, Roland R Griffiths
Page
of 14